Friday, 16 October 2026European Markets

TotalEnergiesGabon, DNO, Another 2 Companies Have A High Dividend Yield And Return On Equity In The Oil & Gas E&P Industry.

Loading stream...

(vianews) - totalenergiesgabon (ec.pa) is among this list of stock assets with the highest dividend rate and return on equity on the oil & gas e&p industry.

financial asset price forward dividend yield return on equity
totalenergiesgabon (ec.pa) €159.20 26.69% 20.36%
dno (dno.ol) kr10.48 9.94% 19.33%
aker bp (akrbp.ol) kr310.80 7.87% 11.97%
maurel et prom (mau.pa) €6.51 3.32% 14.41%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. totalenergiesgabon (ec.pa)

26.69% forward dividend yield and 20.36% return on equity

totalenergies ep gabon société anonyme engages in the mining, exploration, and production of crude oil in gabon. it also holds interests in operated and non-operated production fields. the company was formerly known as total gabon. the company was incorporated in 1949 and is headquartered in port gentil, gabon. totalenergies ep gabon société anonyme is a subsidiary of totalenergies se.

earnings per share

as for profitability, totalenergiesgabon has a trailing twelve months eps of €71.73.

pe ratio

totalenergiesgabon has a trailing twelve months price to earnings ratio of 2.22. meaning, the purchaser of the share is investing €2.22 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.36%.

moving average

totalenergiesgabon's worth is under its 50-day moving average of €167.96 and below its 200-day moving average of €173.11.

volatility

totalenergiesgabon's last week, last month's, and last quarter's current intraday variation average was a negative 0.13%, a positive 0.03%, and a positive 1.08%.

totalenergiesgabon's highest amplitude of average volatility was 1.40% (last week), 0.87% (last month), and 1.08% (last quarter).

dividend yield

as maintained by morningstar, inc., the next dividend payment is on jun 7, 2023, the estimated forward annual dividend rate is 41.22 and the estimated forward annual dividend yield is 26.69%.

more news about totalenergiesgabon.

2. dno (dno.ol)

9.94% forward dividend yield and 19.33% return on equity

dno asa engages in the exploration, development, and production of oil and gas assets in the middle east, the north sea, and west africa. its flagship project is the tawke field that is located in the kurdistan region of iraq. the company was founded in 1971 and is headquartered in oslo, norway.

earnings per share

as for profitability, dno has a trailing twelve months eps of kr0.53.

pe ratio

dno has a trailing twelve months price to earnings ratio of 19.77. meaning, the purchaser of the share is investing kr19.77 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.33%.

moving average

dno's value is higher than its 50-day moving average of kr10.23 and below its 200-day moving average of kr11.31.

growth estimates quarters

the company's growth estimates for the ongoing quarter and the next is a negative 65.6% and a negative 86.7%, respectively.

yearly top and bottom value

dno's stock is valued at kr10.48 at 11:40 est, way below its 52-week high of kr15.20 and way higher than its 52-week low of kr9.30.

more news about dno.

3. aker bp (akrbp.ol)

7.87% forward dividend yield and 11.97% return on equity

aker bp asa explores for, develops, and produces oil and gas on the norwegian continental shelf. the company was formerly known as det norske oljeselskap asa and changed its name to aker bp asa in october 2016. aker bp asa was founded in 2001 and is headquartered in fornebu, norway.

earnings per share

as for profitability, aker bp has a trailing twelve months eps of kr19.04.

pe ratio

aker bp has a trailing twelve months price to earnings ratio of 16.32. meaning, the purchaser of the share is investing kr16.32 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.97%.

moving average

aker bp's worth is way above its 50-day moving average of kr268.61 and way higher than its 200-day moving average of kr281.35.

revenue growth

year-on-year quarterly revenue growth grew by 62.4%, now sitting on 15.29b for the twelve trailing months.

growth estimates quarters

the company's growth estimates for the current quarter and the next is a negative 35.7% and a negative 20.2%, respectively.

yearly top and bottom value

aker bp's stock is valued at kr310.80 at 11:40 est, way under its 52-week high of kr372.90 and way higher than its 52-week low of kr234.00.

more news about aker bp.

4. maurel et prom (mau.pa)

3.32% forward dividend yield and 14.41% return on equity

etablissements maurel & prom s.a., an oil and gas exploration company, engages in the exploration and production of hydrocarbons. it operates through three segments: exploration, production, and drilling. the company was founded in 1831 and is headquartered in paris, france. etablissements maurel & prom s.a. is a subsidiary of pt pertamina internasional eksplorasi dan produksi.

earnings per share

as for profitability, maurel et prom has a trailing twelve months eps of €0.55.

pe ratio

maurel et prom has a trailing twelve months price to earnings ratio of 11.84. meaning, the purchaser of the share is investing €11.84 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.41%.

more news about maurel et prom.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com